QuantaMatrix is targeting $17.80 to $22.30 per share under a regulation permitting a listing on the basis of growth and technology potential.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

UT Southwestern-linked CNS disease drug developer Taysha has filed to raise up to $100m in an IPO, just weeks after its $96m series B.

The CNS disease drug developer has filed to raise up to $100m in an initial public offering, just weeks after raising $96m from investors including GV.

The WuXi AppTec and Medtronic-backed plasma ablation system provider has bagged a nine-figure renminbi amount in a round led by CICC Capital.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

SoftBank Vision Fund 2 led a $100m series C round for the healthcare data analytics provider that included existing investor MassMutual Ventures.

Health insurer Centene was among the investors in a $33.5m round that marked paediatric care service Hazel's first publicly disclosed financing.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Stanford-StartX Fund-backed PicnicHealth has now secured at least $37m in funding altogether after disclosing series A and B funding.